An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 682 followers.

RT @jwmdebacker: A well-powered study with #fri as primary endpoint shows the potential of an inhaled PI3K delta inhibitor in #copd exacerb…

Reply Repost Favourite

A well-powered study with #fri as primary endpoint shows the potential of an inhaled PI3K delta inhibitor in #copd exacerbations. @FluiddaNV @OINDPnews @GSK https://t.co/5HzckFXdxT

Reply Repost Favourite